Oruka Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2021 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Oruka Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2021 to 2023.
  • Oruka Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.18 USD/shares, a 80% decline year-over-year.
  • Oruka Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -0.5 USD/shares, a 16.3% decline year-over-year.
  • Oruka Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -0.37 USD/shares, a 46.4% increase from 2022.
  • Oruka Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -0.69 USD/shares, a 50.4% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 +$0.32 +46.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-01
2022 -$1 +$0.70 +50.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-01
2021 -$1 Jan 1, 2021 Dec 31, 2021 10-K 2023-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.